Core Viewpoint - On September 11, Oriental Bio held a performance briefing for the first half of 2025, highlighting its focus on expanding its animal health products, particularly vaccines and diagnostic reagents, in both domestic and European-American markets [1] Company Summary - The management indicated that the company is accelerating the registration of products in the domestic and European-American markets based on existing certified products [1]